Klinik Psikiyatri Dergisi, cilt.28, sa.4, ss.374-379, 2025 (ESCI, Scopus, TRDizin)
The rising number of child and adolescent psychiatry referrals, along with the growing use of medications for mental health problems, has led to an increased incidence of drug-induced parkinsonism (DIP). This report aims to document a patient with DIP, which is rarely seen in child and adolescent psychiatry clinical practice, and to present the successful treatment of this patient with amantadine. Amantadine represents an evidence-based pharmacologic option for treating drug-induced parkinsonism.